Teva Pharmaceuticals Reaches $80 Million Settlement with Baltimore Over Opioid Crisis

Teva Settles Baltimore Opioid Case for $80 Million

Teva Pharmaceuticals has reached an $80 million settlement with Baltimore in response to allegations that the company played a substantial role in perpetuating the city’s opioid epidemic. The lawsuit, part of a broader effort by Baltimore to hold opioid manufacturers and distributors accountable, culminated in this significant payout, which Baltimore Mayor Brandon M. Scott described as a victory for the city’s ongoing fight against opioid addiction. This settlement follows Baltimore’s decision to reject a national settlement with Teva, ultimately securing a more favorable outcome. The funds will be directed toward essential recovery programs, education initiatives, and outreach efforts to address the lasting impact of opioid misuse in the city.

5 Key Points

• Teva Pharmaceuticals has agreed to pay $80 million to settle claims regarding its involvement in Baltimore’s opioid crisis.
• Baltimore rejected the national settlement with Teva, opting for a local deal, resulting in a payout more than seven times larger than the national proposal.
• The settlement will support opioid-related recovery initiatives, including $5 million for public education about the 988 mental health hotline and $3 million for the Penn North Recovery Center.
• This settlement is the fourth in a series of agreements related to Baltimore’s opioid litigation, bringing the city’s total recoveries to over $322 million.
• The legal battle against other opioid defendants continues, with the next trial scheduled to begin later this month.

Context of the Settlement

The opioid epidemic has devastated communities across the United States, and Baltimore has been one of the cities hit hardest. Teva Pharmaceuticals, one of the world’s largest generic drug manufacturers, was implicated in Baltimore’s opioid litigation due to its alleged role in distributing addictive opioids. This settlement marks the fourth major victory for the city, which had previously secured agreements with other pharmaceutical giants, including Allergan, CVS, and Cardinal Health. The combined settlements now exceed $322.5 million, which will be used to bolster Baltimore’s opioid crisis response efforts.

Get a free legal case review today

Did you develop any of the following injuries after being exposed to Fire Fighting Foam (AFFF)? * Choose one Ulcerative Colitis Kidney Cancer Pancreatic Cancer Testicular Cancer Prostate Cancer Bladder Cancer Thyroid Disease Liver Cancer Non-Hodgkin's Lymphoma None of the above Were you exposed to Fire Fighting Foam (AFFF)? *

YesNo

Which medication(s) did you take during your pregnancy? * Choose one Tylenol Acetaminophen Alka-Seltzer Coricidin Dayquil Excedrin FluTherapy Midol Mucinex Nyquil Panadol Robitussin Sinex Sudafed Theraflu Other Medication(s) Was your child diagnosed with Autism, ADHD or another condition? * Choose one Autism/Autism Spectrum Disorder (ASD) Attention Deficit Hyperactivity Disorder (ADHD) Asperger’s Syndrome Kanner’s Syndrome Childhood Disintegrative Disorder Pervasive Developmental Disorder Other Medical Condition How old was your child at the time of diagnosis? *

Under 18 years old18+ years old

Did the accident occur within the last 2 years? *

YesNo

First Name *

Last Name *

Email Address *

ZIP Code *

Phone Number *

What is your case type? * Choose one -------------------- Asbestos Baby Formula Camp Lejeune Clergy Abuse CPAP Elmiron Exactech Firefighting Foam FTX Exchange Hair Relaxer Hernia Mesh Paraquat PFAS Roundup Sex Abuse Social Media Talcum Powder Tepezza Tylenol -------------------- Birth Injury Car Accident FELA Medical Malpractice Motorcycle Accident Slip and Fall Trucking Accident Uber & Lyft Rideshare Workplace Injury Weight Loss Wrongful Death -------------------- Something Else

Human Verification *

I understand and agree that (a) submitting this form does not create an attorney-client relationship, (b) I am not already represented by an attorney for this matter, (c) the information I submit will be shared with a law firm, and (d) I have read and accepted the terms and conditions of the Privacy Policy, Terms of Service and Legal Disclaimer. Further, I consent to being contacted by a law firm or its agent after submitting this request.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Allocation of the Settlement Funds

Mayor Brandon M. Scott outlined a detailed plan for allocating the funds from the Teva settlement. A portion will be devoted to enhancing public education about the 988 mental health hotline, a critical service for individuals in crisis. In addition, $3 million will be allocated to the Penn North Recovery Center, which has been instrumental in providing addiction recovery services to the community. Another $2 million will go to BMore Power, a grassroots organization focused on outreach and harm reduction. The remaining funds will be distributed through a comprehensive framework established by Mayor Scott’s executive order, ensuring that resources are used effectively to combat the opioid epidemic on multiple fronts.

Future of Opioid Litigation in Baltimore

Despite the success of this settlement, the city’s legal battle against other opioid manufacturers and distributors continues. The defendants who controlled over half the opioid market in Baltimore have yet to settle, and the city’s subsequent trial is slated to begin soon. Mayor Scott emphasized that while these settlements cannot undo the damage caused by the opioid crisis, they represent a crucial step toward healing and recovery for the community. The funds will allow Baltimore to take a multifaceted approach to addressing the epidemic, from public health initiatives to direct support for those affected by addiction.